Expression of Interest (EOI) for Co Developing and manufacturing Devices for COVID-19 Pandemic

Many technologies on offer from SCTIMST: https://www.sctimst.ac.in/COVID-19/

SCTIMST invites manufacturers/start ups/social groups who are interested in working with Institute to co-develop and manufacture medical devices on a fast track mode to support the distressing situation the epidemic COVID 19 has created. Please join us for development and manufacture of devices such as :

• Ambu bag based Ventilator
• Ventilator Sharing Kit
• Battery Operated Assistive Breathing Unit
• Isolation Pods
• Disposable Safety Face Shield
• Deployable Field Units

For further details, please contact Technology Business Division : tbd@sctimst.ac.in
Call us : Mr S. Balram (9249402311)/ Ms Sandhya C.G (9895098086)
License to WIPRO 3D is in news.

Is HemoGlobe device a US version of Indian innovation Biosense?

The Indian Innovation for detecting anemia in a non-invasive way is now on the road to commercialization by  Biosense, the start-up. The HemoGlobe was developed as part of a competition for a $250,000 seed grant in the Saving Lives at Birth: A Grand Challenge for Development competition funded in part by the U.S. Agency for International Development and the Bill & Melinda Gates Foundation.(source:gigmag). 
Which is the original? 

Application process is now open for the 2013 Stanford-India Biodesign (SIB) Fellowship

Application process is now open for the 2013 Stanford-India Biodesign (SIB) Fellowship. The goal of this programme, launched in 2007, is to train the next generation of biomedical technology innovators in India. This highly competitive programme is directed to Indian citizens who have an interest in the invention and early-stage development of new biomedical technologies.  

Fellows receive tuition, stipend support, and international travel arrangements. Over the course of the 1 year fellowship, approximately half of the fellows’ time will be spent at Stanford University and the other half in India. Fellows work on a multidisciplinary team joining other innovators with a combination of engineering, medical and business backgrounds. Preference will be given to applicants with significant work experience.

The fellowship application deadline is May 18th, 2012. Select applicants will be interviewed in Delhi. The fellowship starts at Stanford in January 2013.

A detailed programme description and fellowship application are available at the Stanford Biodesign Programme website: http://biodesign.stanford.edu/bdn/india

For further programme details, please contact info@sibiodesign.org.